-
1
-
-
12344288007
-
Solid lipid microparticles: Formulation, preparation characterization, drug release and applications - A review
-
Jaspart S, Piel G, Delattre, L. Solid lipid microparticles: formulation, preparation characterization, drug release and applications- a review. Expert Opin Drug Deliv. 2005; 2: 1-12.
-
(2005)
Expert Opin Drug Deliv.
, vol.2
, pp. 1-12
-
-
Jaspart, S.1
Piel, G.2
Delattre, L.3
-
2
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
-
DOI 10.1016/S0939-6411(00)00087-4, PII S0939641100000874
-
Muller RH, Mader K, Gohla S. Solid lipid nanoparticles for controlled drug delivery - a review of the state of art. Eur. J Pharm Biopharm. 2000; 50: 161-177. (Pubitemid 30326695)
-
(2000)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.50
, Issue.1
, pp. 161-177
-
-
Muller, R.H.1
Mader, K.2
Gohla, S.3
-
3
-
-
0025807867
-
Simultaneous optimization for several characteristics concerning percutaneous absorption and skin damage of ketroprofen hydrogels containing d-limonene
-
Takayama K, Nagai, T. Simultaneous optimization for several characteristics concerning percutaneous absorption and skin damage of ketroprofen hydrogels containing d-limonene. Int J Pharm. 1991; 74: 115-126.
-
(1991)
Int J Pharm.
, vol.74
, pp. 115-126
-
-
Takayama, K.1
Nagai, T.2
-
4
-
-
0028104190
-
Steady state pharmacokinetics of a sustained release formulation of ketoprofen in comparison with normal release formulation
-
De Bernardi DVM, Tripodi, AS, Contos S. Steady state pharmacokinetics of a sustained released formulation of ketoprofen in comparison with normal release formulation. Acta Toxicol Ther. 1994; 15: 93-112. (Pubitemid 24373951)
-
(1994)
Acta Toxicologica et Therapeutica
, vol.15
, Issue.2
, pp. 93-112
-
-
De Bernardi, D.V.M.1
Tripodi, A.S.2
Contos, S.3
-
5
-
-
0005551850
-
Enhancement of bioavailability of ketoprofen using dry elixir as a novel dosage form
-
Ahm HJ, Kim KM, Kim CK. Enhancement of bioavailability of ketoprofen using dry elixir as a novel dosage form. Drug Dev Ind Pharm 1998; 24: 697-701. (Pubitemid 28312311)
-
(1998)
Drug Development and Industrial Pharmacy
, vol.24
, Issue.7
, pp. 697-701
-
-
Ahn, H.J.1
Kim, K.M.2
Kim, C.-K.3
-
6
-
-
0342804390
-
Possible mechanism for drug retardation from glyceryl monostearate matrix system
-
DOI 10.1081/DDC-100101252
-
Peh KK, Wong CF, Yuen KH. Possible mechanism for drug retardation from glyceryl monostearate matrix system. Drug Dev Ind Pharm. 2000; 26: 447-450. (Pubitemid 30207717)
-
(2000)
Drug Development and Industrial Pharmacy
, vol.26
, Issue.4
, pp. 447-450
-
-
Peh, K.K.1
Wong, C.F.2
Yuen, K.H.3
-
7
-
-
0029871566
-
In-vivo performance of a multiparticulate matrix controlled release theophylline
-
Peh KK, Yuen KH. In-vivo performance of a multiparticulate matrix controlled release theophylline. Drug Dev Ind Pharm. 1995; 22: 349-355.
-
(1995)
Drug Dev Ind Pharm.
, vol.22
, pp. 349-355
-
-
Peh, K.K.1
Yuen, K.H.2
-
8
-
-
60149096788
-
Polymeric Nano-half-shells prepared by simple solvent evaporation method
-
Kwon S, Joo J, Lee W, Jeong Y, Choi J. Polymeric Nano-half-shells prepared by simple solvent evaporation method. Bull. Korean Chem. Soc. 2009; 30:486-488.
-
(2009)
Bull. Korean Chem. Soc.
, vol.30
, pp. 486-488
-
-
Kwon, S.1
Joo, J.2
Lee, W.3
Jeong, Y.4
Choi, J.5
|